Trial intelligence / Profile preview

Tolterodine plus tamsulosin for chronic prostatitis/chronic pelvic pain syndrome

ChiCTR-TRC-09000391Phase 4Completed

Sponsor
Fuling Central Hospital
Start
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tolterodine and tamsulosin in Prostatodynia (CP/CPPS) (2 arms), sponsored by Fuling Central Hospital. Primary endpoints: CPSI pain score, CPSI quality of life score and 2 more. Started Aug 2009; status: completed.

02

Drugs

tolterodinetamsulosin
03

Conditions

Prostatodynia (CP/CPPS)

Beyond the preview

Go deeper on ChiCTR-TRC-09000391.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-09000391.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call